Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 107

Sort by

Sort Order Select

Journal Articles

HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms

Blood (2020) 135 (3): 191–207.

https://doi.org/10.1182/blood.2019895326

Published: 2020

Includes: Supplemental data

Journal Articles

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model

Blood (2017) 130 (2): 146–155.

https://doi.org/10.1182/blood-2016-08-731505

Published: 2017

Includes: Supplemental data

Journal Articles

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Chetasi Talati, MD, Andrew Kuykendall, MD, Jori Kaplan, MD, Jose D Sandoval-Sus, MD, Samir Dalia, MD, Bijal D. Shah, MD, Celeste M. Bello, MD, Farhad Khimani, MD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, Julio C. Chavez, MD

Blood (2016) 128 (22): 1870.

https://doi.org/10.1182/blood.V128.22.1870.1870

Published: 2016

Journal Articles

The Neutrophil-to-Lymphocyte Ratio Is Prognostic in Patients with Early Stage Peripheral T-Cell Lymphoma

Brady E Beltran, MD, Denise Castro, MD, Rodrigo Motta, MD, Sally Paredes, MD, Jose M Malaga, MD, Roberto N. Miranda, MD, Eduardo M. Sotomayor, MD, Jorge J. Castillo, MD

Blood (2016) 128 (22): 5346.

https://doi.org/10.1182/blood.V128.22.5346.5346

Published: 2016

Journal Articles

Histone Deacetylase 11 (HDAC11) Interaction with Ikaros Represent a Novel Mechanism of Regulation of Essential Transcriptional Factors in CD4+ T Cells

Jie Chen, PhDCandidate, Fengdong Cheng, MD, David Michael Woods, PhD, Edward Seto, PhD, Alejandro Villagra, PhD, Eduardo M. Sotomayor, MD

Blood (2016) 128 (22): 864.

https://doi.org/10.1182/blood.V128.22.864.864

Published: 2016

Journal Articles

The Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with EBV-Positive Diffuse Large B-Cell Lymphoma

Brady E Beltran, MD, Jose M Malaga, MD, Julio C Chavez, MD, Eduardo M. Sotomayor, MD, Jorge J Castillo, MD

Blood (2015) 126 (23): 5047.

https://doi.org/10.1182/blood.V126.23.5047.5047

Published: 2015

Journal Articles

JQ1, a Selective Bromodomain Inhibitor, Augment the Immunogenicity of Mantle Cell Lymphoma By Influencing the Expression of PD-L1

Hongwei Wang, MD, Fengdong Cheng, MD, Jie Cheng, PhD, Alejandro Villagra, PhD, Jianguo Tao, MD PhD, James E. Bradner, MD, Eduardo M. Sotomayor, MD

Blood (2015) 126 (23): 822.

https://doi.org/10.1182/blood.V126.23.822.822

Published: 2015

Journal Articles

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Jose D Sandoval-Sus, MD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Viet Q. Ho, PharmD, RPh, BCOP, Lisa Nodzon, PhDANP, Mohamed A. Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD PhD, Javier Pinilla-Ibarz

Blood (2015) 126 (23): 2945.

https://doi.org/10.1182/blood.V126.23.2945.2945

Published: 2015

Journal Articles

A Novel Role for Histone Deacetylase 11 (HDAC11) in B Cell Lymphopoiesis and Plasma Cell Survival in Multiple Myeloma

Jason B. Brayer, MDPhD, Eva Sahakian, PhD, John Powers, M.S., Mark B Meads, PhD, Susan Deng, Allison Distler, Melissa Alsina, MD, Taiga Nishihori, MD, Rachid Baz, MD, Alejandro Villagra, PhD, Javier Pinilla-Ibarz, MD PhD, Eduardo M. Sotomayor, MD, Kenneth H. Shain, MD PhD

Blood (2014) 124 (21): 4715.

https://doi.org/10.1182/blood.V124.21.4715.4715

Published: 2014

Journal Articles

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Patrick T. Griffin, MD, Samir Dalia, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Eduardo M. Sotomayor, MD, Julio C Chavez, MD

Blood (2014) 124 (21): 2981.

https://doi.org/10.1182/blood.V124.21.2981.2981

Published: 2014

Journal Articles

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Bijal D. Shah, MD, Jianguo Tao, MD PhD, Paul A. Chervenick, MD, Marcie L Riches, MD MS, Javier Pinilla-Ibarz, MD PhD, Lynn C. Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, MD, Sophie Dessureault, MD

Blood (2014) 124 (21): 3083.

https://doi.org/10.1182/blood.V124.21.3083.3083

Published: 2014

Journal Articles

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Patrick T. Griffin, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Lubomir Sokol, MD PhD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Jianguo Tao, MD PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD

Blood (2014) 124 (21): 4424.

https://doi.org/10.1182/blood.V124.21.4424.4424

Published: 2014

Journal Articles

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Tessa Knox, MS, Maritza Lienlaf, MS, Patricio Perez-Villarroel, BS., Calvin Lee, MD, Eva Sahakian, PhD, John J. Powers, B.S., Fengdong Cheng, MD, Jorge Canales, MS, Danay Marante, MS, Ed Seto, PhD, Eduardo M. Sotomayor, MD, Alejandro Villagra, PhD, Pedro Horna, MD

Blood (2014) 124 (21): 5423.

https://doi.org/10.1182/blood.V124.21.5423.5423

Published: 2014

Journal Articles

Selective Inhibition of Histone Deacetylase 6 (HDAC6) and HDAC3 As a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)

Fengdong Cheng, MD, Bing Xia, MD, Eva Sahakian, PhD, Tint Lwin, MD PhD, Hongwei Wang, MD, Limin Xing, MD, Bijal D. Shah, MD, Patricio PerezVillarroel, BS, Maritza LienlafMoreno, BS, Yizhuo Zhang, MD, Steven N Quayle, PhD, Simon S Jones, PhD, Javier Pinilla-Ibarz, MD PhD, Alejandro Villagra, PhD, Eduardo M. Sotomayor, MD, Jianguo Tao, MD PhD

Blood (2014) 124 (21): 5397.

https://doi.org/10.1182/blood.V124.21.5397.5397

Published: 2014

Journal Articles

Lymphopenia Is an Adverse Prognostic Factor in EBV-Positive Diffuse Large B-Cell Lymphoma

Brady E Beltran, MD, Julio C Chavez, MD, Eduardo M. Sotomayor, MD, Jorge J. Castillo, MD

Blood (2014) 124 (21): 5408.

https://doi.org/10.1182/blood.V124.21.5408.5408

Published: 2014

Journal Articles

The Prognostic Value of the Neutrophil to Lymphocyte Ratio in 209 Patients with Peripheral T-Cell Lymphoma

Brady E Beltran, MD, Denisse Castro, MD, Julio C Chavez, MD, Eduardo M. Sotomayor, MD, Jorge J. Castillo, MD

Blood (2014) 124 (21): 1675.

https://doi.org/10.1182/blood.V124.21.1675.1675

Published: 2014

Journal Articles

Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL)

John J. Powers, B.S., Kamira K. Maharaj, B.S., Eva Sahakian, PhD, Limin Xing, PhD, Patricio PerezVillarroel, BS, Tessa Knox, MS, Steven Quayle, Simon S Jones, PhD, Alejandro Villagra, PhD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2014) 124 (21): 3311.

https://doi.org/10.1182/blood.V124.21.3311.3311

Published: 2014

Journal Articles

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Jie Chen, MA, Eva Sahakian, PhD, John J. Powers, B.S., Maritza LienlafMoreno, BS, Limin Xing, PhD, Susan Deng, Allison Distler, Fengdong Cheng, MD, Alejandro Villagra, PhD, Pedro Horna, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2014) 124 (21): 225.

https://doi.org/10.1182/blood.V124.21.225.225

Published: 2014

Journal Articles

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Samir Dalia, MD, Samantha L Price, PharmD, Peter Forsyth, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Michael V. Jaglal, MD

Blood (2013) 122 (21): 3040.

https://doi.org/10.1182/blood.V122.21.3040.3040

Published: 2013

Journal Articles

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Lubomir Sokol, MD, Ph.D, Jianguo Tao, MD, PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD

Blood (2013) 122 (21): 5057.

https://doi.org/10.1182/blood.V122.21.5057.5057

Published: 2013

NARROW

HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms

T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

The Neutrophil-to-Lymphocyte Ratio Is Prognostic in Patients with Early Stage Peripheral T-Cell Lymphoma

Histone Deacetylase 11 (HDAC11) Interaction with Ikaros Represent a Novel Mechanism of Regulation of Essential Transcriptional Factors in CD4+ T Cells

The Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with EBV-Positive Diffuse Large B-Cell Lymphoma

JQ1, a Selective Bromodomain Inhibitor, Augment the Immunogenicity of Mantle Cell Lymphoma By Influencing the Expression of PD-L1

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

A Novel Role for Histone Deacetylase 11 (HDAC11) in B Cell Lymphopoiesis and Plasma Cell Survival in Multiple Myeloma

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Selective Inhibition of Histone Deacetylase 6 (HDAC6) and HDAC3 As a Novel Therapeutic Strategy in Mantle Cell Lymphoma (MCL)

Lymphopenia Is an Adverse Prognostic Factor in EBV-Positive Diffuse Large B-Cell Lymphoma

The Prognostic Value of the Neutrophil to Lymphocyte Ratio in 209 Patients with Peripheral T-Cell Lymphoma

Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL)

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Locally Directed Therapy In Limited Stage Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only